SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

The pharmaceutical industry as a medicines provider · Study

ReviewThe pharmaceutical industry as a medicines provider

David A Henry2002

Review2002

The pharmaceutical industry as a medicines provider

David A Henry · Joel Lexchin

165 citations·0/0 files stored·The Lancet

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Intellectual Property and Patents Pharmaceutical Quality and Counterfeiting

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 165 citations exist upstream.

References

1991Cost of innovation in the pharmaceutical industry 1999Access to Essential Drugs in Poor Countries 1995Success rates for new drugs entering clinical testing in the United States 2002IMPLICATIONS OF THE DOHA DECLARATION ON THE TRIPS AGREEMENT AND PUBLIC HEALTH

Cited by

2007Prices & availability of common medicines at six sites in India using a standard methodology.2011Does the Market Share of Generic Medicines Influence the Price Level?2008The Effect Of Regulation On Pharmaceutical Revenues: Experience In Nineteen Countries 2005GLOBAL TRADE AND PUBLIC HEALTH 2007TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines?2011Promoting Global Cardiovascular Health 2006Fair trade for surgical instruments 2008“Backstage solidarity” in Spanish‐ and English‐written medical research papers: Publication context and the acknowledgment paratext

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2005Drug Prices and Research and Development Investment Behavior in the Pharmaceutical Industryarticle · 2 shared references 2000Creating Markets for New Vaccines Part I: Rationalereport · 2 shared references 2000New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical Firmsarticle · 2 shared references 2000Creating Markets for New Vaccines. Part I: Rationalearticle · 2 shared references 2004Valuation and design of pharmaceutical R&D licensing dealsarticle · 2 shared references 2016Essential medicines for universal health coveragereview · 1 shared reference

Details

Year2002

Typereview

Published2002-11-01

VenueThe Lancet

ISSN-L0099-5355

Languageen

Citations165

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1016/s0140-6736(02)11527-3

openalex_workW2127520342

Links

Imported from OpenAlex (CC0) — nothing here is generated.